Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
ID:
Password:
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

Agents/Distributors
 Regional Subscription Agents/Distributors
 
Current Topics in Pharmacology   Volumes    Volume 13  Issue 1
Abstract
S-1, a novel oral fluoropyrimidine delivative: A role for colorectal cancer
Kazuhiko Yoshimatsu, Hajime Yokomizo, Kenji Ogawa
Pages: 85 - 89
Number of pages: 5
Current Topics in Pharmacology
Volume 13  Issue 1

Copyright © 2009 Research Trends. All rights reserved

ABSTRACT
 
S-1 developed as a novel oral fluoropyrimidine delivative in Japan is a potent antitumor drug in cancer including colorectal and gastric cancer. Several studies have recently demonstrated the efficacy of S-1 in both the single administration and combination settings for the treatment of unresectable advanced colorectal cancer. Also, clinical trials are progressing for adjuvant therapy after curative resection of colon and rectal cancer. In this minireview, we comment on the therapeutic efficacy of S-1 for colorectal cancer.
Buy this Article


 
search


E-Commerce
Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Login
Search Products
Browse in Alphabetical Order : Journals
Series/Books
Browse by Subject Classification : Journals
Series/Books

Miscellaneous
Ordering Information Ordering Information
Downloadable forms Downloadable Forms